These results indicated that transfer of miR‐25‐3p‐containing CHB‐PNALT‐Exo promoted the proliferation and metastasis of HBV‐positive liver cancer by inhibiting the co‐expression of TCF21 and HHIP. Here, TCF21 is linked to liver cancer.